Commission: I, ………(applicant’s name)………., a certified public accountant No.………………..., working with ………….(name of the audit firm)…………., hereby certify as follows: 1. My immediate family members, including

size of all transactions in the past 6 months also does not exceed the 15 percent threshold limits as prescribed in the regulations. The transaction takes place with immediate effect. For further

size of all transactions in the past 6 months also does not exceed the 15 percent threshold limits as prescribed in the regulations. The transaction closes with immediate effect. For further information

in its R&D research and more than 2 product sectors with up to 5 customer bases. By combine both parties’ strength and competitive factors, it shall enhance the new CCPH for more business revenue

,especially the corrosive prevention part. Therefore, company would invest new research and development for appropriate products to suit Thai climate and environments. Please be informed. Yours Sincerely, Mr

FINANCIAL REVIEW AND PROSPECTS A. Operating Results ผลการดําเนินงาน B. Liquidity and Capital Resources แหลงเงินทุนและสภาพคลอง C. Research & Development, Patents and License, etc. การวิจัยและพัฒนา D. Trend

: - Industry analysis: - Study and analysis of fundamental factors of the business to be invested. (3) Prescription of criteria for selecting an analysis/a research to support an investment decision. (4

Laboratory and Research Center (“AMARC”). Costs and Expenses  The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by

booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC

to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing